DRL

Location

Vlaams Brabant

Founded

1980-09-05

Risk Signals

105 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Furniture, Catalog and Mail-Order Houses), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about DRL

Live alerts from global media, monitored by Business Radar

Novo Nordisk diabetes / weightloss drug semaglutide locked in a legal tangle with DRL - The Hindu

2025-05-31 (thehindubusinessline.com)

Novo Nordisk diabetes / weightloss drug semaglutide locked in a legal tangle with DRL - The Hindu

Legal battle over Novo Nordisk's semaglutide drug in India, with DRL, raises concerns over patent infringement and drug availability.

Read more
No observations by US FDA during plant inspection: DRL

2024-09-21 (economictimes.com)

No observations by US FDA during plant inspection: DRL

Dr. Reddy's Laboratories announced that the U.S. Food & Drug Administration (FDA) completed a routine Good Manufacturing Practice (GMP) inspection of its integrated product development organization in Bachupally, Hyderabad, with zero observations.

Read more
Dr Reddy's Laboratories eyes mega brand in UK - Healthcare News | The Financial Express

2024-01-17 (financialexpress.com)

Dr Reddy's Laboratories eyes mega brand in UK - Healthcare News | The Financial Express

Nicotinell, which is sold in patch, gum and lozenge form, is said to be the second-largest nicotine replacement therapy product globally.Dr Reddy's Laboratories eyes mega brand in UK.

Read more
DRL's Visakhapatnam unit gets six observations by German regulator -

2017-09-08 (expresspharma.in)

DRL's Visakhapatnam unit gets six observations by German regulator -

The facility's compliance with the CAPA and other applicable regulations will be reviewed again by the regulator by November 2018 for continuation of EU-GMP certification

Read more
DRL receives US FDA approval for treatment of acute migraine episodes -

2016-02-01 (expresspharma.in)

DRL receives US FDA approval for treatment of acute migraine episodes -

ZEMBRACESymTouch is available as a prefilled, ready-to-use, single-dose disposable autoinjector containing 3 mg of sumatriptan US Food and Drug Administration (US FDA) has approved Dr Reddy's Laboratories (DRL's) ZEMBRACESymTouch (sumatriptan […]

Read more
US FDA warns of serious data integrity violations at DRL -

2015-11-26 (expresspharma.in)

US FDA warns of serious data integrity violations at DRL -

The US Food and Drug Administration has warned DRL over serious data integrity violations, placing all its new applications or supplements under a cloud The US Food and Drug Administration […]

Read more
DRL gets FDA inspection report for Vizag units

(bizzbuzz.news)

DRL gets FDA inspection report for Vizag units

Hyderabad: Dr Reddy's Laboratories Ltd on Monday said it has received an Establishment Inspection Report (EIR) from the US health regulator for its formulations manufacturing units at Duvvada in...

Read more
DRL inks pact with Amgen to market three drugs in India - ET HealthWorld | Pharma

(indiatimes.com)

DRL inks pact with Amgen to market three drugs in India - ET HealthWorld | Pharma

Under the terms of collaboration, DRL will commercialise Xgeva (denosumab), Vectibix (panitumumab) and Prolia (denosumab) in India, a company statement said today.

Read more

Never miss a headline about DRL

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages